WoS SCIE & CAS Academic Rankings
Global Journal Rankings & Directory
Explore academic hierarchies, Clarivate Impact Factors, Web of Science Q1–Q4 quartiles, and CAS divisions.
Showing 101–125 of 232 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Impact Factor | H-Index | WoS Quartile | Scopus SJR | CAS Division | Self-Citation | Docs/yr | Publisher |
|---|---|---|---|---|---|---|---|---|---|
| #101 | Journal of Geriatric Oncology ISSN: 1879-4068 / 1879-4076 | 2.9 | 63 | Q3 | 0.943Q2 | CAS Tier 3 | 16.7% | 187 | Elsevier Ltd |
| #102 | Hereditary Cancer in Clinical Practice ISSN: 1731-2302 / 1897-4287 | 2.8 | 36 | Q3 | 1.049Q2 | CAS Tier 3 | 5% | 45 | BioMed Central |
| #103 | World Journal of Surgical Oncology ISSN: 1477-7819 | 2.8 | 87 | Q3 | 0.761Q1 | CAS Tier 3 | 4% | 341 | BioMed Central |
| #104 | Acta Oncologica ISSN: 0284-186X / 1651-226X | 2.7 | 127 | Q3 | 0.952Q1 | CAS Tier 3 | 7.4% | 186 | Informa Healthcare |
| #105 | Chinese Clinical Oncology ISSN: 2304-3865 / 2304-3873 | 2.7 | 44 | Q3 | 0.636Q2 | CAS Tier 4 | 4.8% | 48 | AME Publishing Company |
| #106 | Clinical Breast Cancer ISSN: 1526-8209 / 1938-0666 | 2.7 | 88 | Q3 | 0.932Q2 | CAS Tier 3 | 3.4% | 146 | Elsevier |
| #107 | Clinical Colorectal Cancer ISSN: 1533-0028 / 1938-0674 | 2.7 | 71 | Q3 | 0.976Q2 | CAS Tier 3 | 0% | 64 | Elsevier |
| #108 | Photodiagnosis and Photodynamic Therapy ISSN: 1572-1000 / 1873-1597 | 2.7 | 82 | Q3 | 0.609Q2 | CAS Tier 3 | 19.4% | 499 | Elsevier |
| #109 | Technology in Cancer Research & Treatment ISSN: 1533-0346 / 1533-0338 | 2.7 | 78 | Q3 | 0.674Q2 | CAS Tier 3 | 3.7% | 256 | SAGE Publications Inc. |
| #110 | Anti-Cancer Agents in Medicinal Chemistry ISSN: 1871-5206 / 1875-5992 | 2.6 | 117 | Q3 | 0.584Q3 | CAS Tier 4 | 3.8% | 231 | Bentham Science Publishers B.V. |
| #111 | Cancer Genomics & Proteomics ISSN: 1109-6535 / 1790-6245 | 2.6 | 53 | Q2 | 0.807Q2 | CAS Tier 3 | 11.5% | 61 | International Institute of Anticancer Research |
| #112 | Cancer Management and Research ISSN: 1179-1322 | 2.6 | 82 | Q3 | 0.789Q2 | CAS Tier 3 | 0% | 814 | Dove Medical Press Ltd. |
| #113 | Clinical Medicine Insights-Oncology ISSN: 1179-5549 | 2.6 | 39 | Q3 | 0.648Q3 | CAS Tier 4 | 0% | 33 | Libertas Academica |
| #114 | ESMO Real World Data and Digital Oncology ISSN: 2949-8201 | 2.6 | — | Q3 | — | — | N/A | — | ELSEVIER |
| #115 | JMIR Cancer ISSN: 2369-1999 | 2.6 | 31 | Q3 | 0.798Q2 | CAS Tier 3 | 3% | 58 | JMIR Publications |
| #116 | Thoracic Cancer ISSN: 1759-7706 / 1759-7714 | 2.6 | 60 | Q3 | 0.779Q2 | CAS Tier 4 | 4.3% | 445 | Blackwell Publishing Asia Pty Ltd |
| #117 | Analytical Cellular Pathology ISSN: 2210-7177 / 2210-7185 | 2.5 | 41 | Q4 | 0.709Q2 | CAS Tier 3 | 0% | 56 | Hindawi Limited |
| #118 | Clinical Oncology ISSN: 0936-6555 / 1433-2981 | 2.5 | 97 | Q3 | 0.926Q1 | CAS Tier 3 | 6.2% | 145 | W.B. Saunders Ltd |
| #119 | Current Cancer Drug Targets ISSN: 1568-0096 / 1873-5576 | 2.5 | 109 | Q3 | 0.726Q2 | CAS Tier 3 | 0% | 70 | Bentham Science Publishers B.V. |
| #120 | European Journal of Cancer Prevention ISSN: 0959-8278 / 1473-5709 | 2.5 | 93 | Q3 | 0.691Q2 | CAS Tier 3 | 4.8% | 64 | Lippincott Williams and Wilkins Ltd. |
| #121 | Japanese Journal of Clinical Oncology ISSN: 0368-2811 / 1465-3621 | 2.5 | 102 | Q3 | 0.652Q2 | CAS Tier 4 | 15.8% | 217 | Oxford University Press |
| #122 | Journal of Cancer Prevention ISSN: 2288-3649 / 2288-3657 | 2.5 | — | Q3 | — | CAS Tier 4 | 0% | 32 | Updating |
| #123 | Neoplasma ISSN: 0028-2685 / 1338-4317 | 2.5 | 62 | Q3 | 0.586Q2 | CAS Tier 4 | 0% | 143 | Vydavatel'stvo Slovenkej Akademie Vied/Veda Publishing House of the Slovak Academy of Sciences |
| #124 | Current Opinion in Oncology ISSN: 1040-8746 / 1531-703XTop Tier | 2.4 | 108 | Q3 | 0.979Q2 | CAS Tier 3 | 0% | 88 | Lippincott Williams and Wilkins Ltd. |
| #125 | Current Problems in Cancer ISSN: 0147-0272 / 1535-6345 | 2.4 | 54 | Q3 | 0.808Q2 | CAS Tier 3 | 0% | 88 | Mosby Inc. |